Microchip forecasts a 1% December-quarter sales dip at midpoint
September’s infrequent revenue changes the comparison behind Microchip’s sales outlook.
Microchip Technology’s December-quarter sales forecast is about 1% below its September result at the midpoint. The chipmaker says September included roughly $53 million of infrequent revenue that it does not expect to repeat.
Its November 5 earnings release puts consolidated sales guidance at $1.573 billion–$1.638 billion for the quarter ending December 31.
The practical question is what the forecast is being compared with. Removing an unusual item from an earlier quarter changes the comparison; it does not add a dollar to the new forecast.
One forecast, two comparison bases
| Sales measure | U.S. dollars, millions |
|---|---|
| Reported September quarter | $1,621.5 |
| September less only the approximate infrequent items | About $1,568.5 |
| December guidance midpoint | $1,605.5 |
September actual sales are reported in the fiscal 2027 second-quarter 10-Q. The other two rows are TrendyVest calculations from the company’s stated inputs, not additional company revenue measures.
The midpoint is about 1% below reported September sales, but about 2.4% above the smaller comparison base. The latter is an illustrative comparison, not a forecast of organic growth or recurring revenue.
A sales adjustment does not establish a profit adjustment
The release does not break down the $53 million or provide its associated costs. Subtracting the revenue therefore cannot establish the effect on operating profit. Assuming every removed sales dollar was profit would turn an incomplete disclosure into a confident earnings forecast.
The range also allows sales growth; its midpoint is not a promised result.
What would resolve the comparison
The useful follow-up is December’s reported revenue, alongside any explanation of acquisitions, product mix or other unusual items. That would make it possible to separate what actually changed in the business from what changed in the comparison.
Microchip’s common shares trade on Nasdaq as MCHP. The release was published November 5 at 4:15 p.m. EST. September refers to the three months ended September 30, 2026; December figures are guidance. No current stock reaction or consensus comparison is asserted.